SEALK

Serial Number 98016345
Registration 7681789
700

Registration Progress

Application Filed
May 26, 2023
Under Examination
Mar 5, 2024
Approved for Publication
Jan 9, 2024
Published for Opposition
Jan 9, 2024
Registered
Feb 4, 2025

Basic Information

Serial Number
98016345
Registration Number
7681789
Filing Date
May 26, 2023
Registration Date
February 4, 2025
Published for Opposition
January 9, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Feb 4, 2025
Registration
Registered
Classes
003 005

Rights Holder

LifeScience Plus, Inc.

03
Address
2520 Wyandotte Street #A
Mountain View, CA 94043

Ownership History

LifeScience Plus, Inc.

Original Applicant
03
Mountain View, CA

LifeScience Plus, Inc.

Owner at Publication
03
Mountain View, CA

LifeScience Plus, Inc.

Original Registrant
03
Mountain View, CA

Legal Representation

Attorney
Neil A. Salyards

USPTO Deadlines

Next Deadline
2036 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2025-02-04)
Due Date
February 04, 2031
Grace Period Ends
August 04, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

36 events
Date Code Type Description
Feb 21, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 21, 2025 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 21, 2025 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 4, 2025 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED
Feb 4, 2025 R.PR A REGISTERED-PRINCIPAL REGISTER
Jan 10, 2025 ALIE A ASSIGNED TO LIE
Jan 10, 2025 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jan 10, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 10, 2025 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jan 10, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 5, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 2, 2024 CNRT W SU - NON-FINAL ACTION - WRITTEN
Dec 2, 2024 GNRT O NON-FINAL ACTION E-MAILED
Dec 2, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 7, 2024 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL
Nov 7, 2024 SUPC I STATEMENT OF USE PROCESSING COMPLETE
Sep 5, 2024 IUAF S USE AMENDMENT FILED
Sep 5, 2024 EISU I TEAS STATEMENT OF USE RECEIVED
Mar 5, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jan 9, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 9, 2024 PUBO A PUBLISHED FOR OPPOSITION
Dec 20, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 6, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 6, 2023 XAEC I EXAMINER'S AMENDMENT ENTERED
Dec 6, 2023 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Dec 6, 2023 GNEA O EXAMINERS AMENDMENT E-MAILED
Dec 6, 2023 CNEA R EXAMINERS AMENDMENT -WRITTEN
Nov 29, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 28, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 28, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 15, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 15, 2023 GNRT F NON-FINAL ACTION E-MAILED
Sep 15, 2023 CNRT R NON-FINAL ACTION WRITTEN
Sep 13, 2023 DOCK D ASSIGNED TO EXAMINER
Jun 28, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 30, 2023 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 003
Wrinkle removing skin care preparations; Wrinkle-minimizing cosmetic preparations for topical facial use; Moisturizing solutions for the skin; Anti-aging moisturizers used as cosmetics; Water soluble hemostasis cellulose matrix,consisting of moisturizing solutions for the skin, anti-aging moisturizers used as cosmetics, wrinkle removing skin care preparations, wrinkle minimizing cosmetic preparations for topical facial use,andliquid solutions and powders for cosmetic skin care, skin regeneration, wrinkle repair, dry skin, and rejuvenation, all of the aforementioned being for cosmetic, not medical, purposes
First Use Anywhere: Oct 1, 2023
First Use in Commerce: Oct 1, 2023
Class 005
Burn dressings; Dissolvable strips to stop bleeding from minor cuts and grazes; Dressings for wounds, burns, and surgery; Drug delivery agents in the form of a dissolvable dressing that facilitate the delivery of pharmaceutical preparations; Hemostatic gel matrix preparations for treating wounds; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Surgical dressings; Medical and surgical dressings;Water soluble hemostasis cellulose matrixconsisting ofdissolvable strips to stop bleeding from minor and major cuts and grazes, hemostatic gel matrix preparation for treating woundsconsisting ofwound dressings, liquid solutions, and powders for wound management, wound care, trauma, burns, surgical wound bleeding control, acute and chronic wound healing, bleeding control, damage control, namely, repairingand healingwounds, tissue growth, skin regeneration, and stem cell growth;Medical matrix, namely, hemostatic gel matrix preparations for treating woundsconsisting ofdissolvable strips to stop bleeding from minor and major cuts and grazes, medical adhesives for binding internal tissue, and dressings that seal the wound as membrane, prevent contamination, and bacteria static, prevent infection, prevent adhesion, modulate growth factors in the post-burn regeneration process, enhance tissue growth, regeneration, and angiogenesis, namely, the formation and differentiation of blood vessels, and inhibit tissue growth factors related to inflammation
First Use Anywhere: Oct 1, 2023
First Use in Commerce: Oct 1, 2023

Additional Information

Translation
The wording SEALK has no meaning in a foreign language.

Classification

International Classes
003 005